DK502786A - Fremgangsmaade til fremstilling af en vaekstfaktor - Google Patents

Fremgangsmaade til fremstilling af en vaekstfaktor

Info

Publication number
DK502786A
DK502786A DK502786A DK502786A DK502786A DK 502786 A DK502786 A DK 502786A DK 502786 A DK502786 A DK 502786A DK 502786 A DK502786 A DK 502786A DK 502786 A DK502786 A DK 502786A
Authority
DK
Denmark
Prior art keywords
fused
preparing
igf
protective peptide
procedure
Prior art date
Application number
DK502786A
Other languages
English (en)
Other versions
DK502786D0 (da
Inventor
Ikuo Ueda
Mineo Niwa
Susumu Satoh
Yoshimasa Saitoh
Chihiro Kusunoki
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858525929A external-priority patent/GB8525929D0/en
Priority claimed from GB868617073A external-priority patent/GB8617073D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of DK502786D0 publication Critical patent/DK502786D0/da
Publication of DK502786A publication Critical patent/DK502786A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK502786A 1985-10-21 1986-10-20 Fremgangsmaade til fremstilling af en vaekstfaktor DK502786A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858525929A GB8525929D0 (en) 1985-10-21 1985-10-21 Production of insulin-like growth factor
GB868617073A GB8617073D0 (en) 1986-07-14 1986-07-14 Insulin-like growth factor i

Publications (2)

Publication Number Publication Date
DK502786D0 DK502786D0 (da) 1986-10-20
DK502786A true DK502786A (da) 1987-04-22

Family

ID=26289914

Family Applications (1)

Application Number Title Priority Date Filing Date
DK502786A DK502786A (da) 1985-10-21 1986-10-20 Fremgangsmaade til fremstilling af en vaekstfaktor

Country Status (10)

Country Link
EP (1) EP0219814B1 (da)
JP (1) JPH07114702B2 (da)
KR (1) KR880001813A (da)
AT (1) ATE67243T1 (da)
CA (1) CA1297814C (da)
DE (1) DE3681398D1 (da)
DK (1) DK502786A (da)
ES (1) ES2029785T3 (da)
GR (1) GR3002696T3 (da)
IL (1) IL80376A0 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3789550T2 (de) * 1986-12-31 1994-08-25 Lucky Ltd Verfahren zur herstellung eines rinderwachstumshormons mittels eines kunstgens.
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
KR920003787B1 (ko) * 1990-03-05 1992-05-14 한국과학기술 연구원 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법
JP2574549B2 (ja) * 1991-03-08 1997-01-22 萩原 義秀 新規プラスミド
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
WO1996007744A1 (en) * 1994-09-08 1996-03-14 Chiron Corporation A method of improved production of insulin-like growth factor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE95236T1 (de) * 1983-04-25 1993-10-15 Chiron Corp Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren.
IL71991A (en) * 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
SE8303626D0 (sv) * 1983-06-23 1983-06-23 Kabigen Ab A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced
WO1985000831A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of insulin-like growth factor
HU194307B (en) * 1983-09-16 1988-01-28 Richter Gedeon Vegyeszet Process for producing plasmidvectors of high copy number
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i

Also Published As

Publication number Publication date
ATE67243T1 (de) 1991-09-15
DE3681398D1 (de) 1991-10-17
GR3002696T3 (en) 1993-01-25
DK502786D0 (da) 1986-10-20
EP0219814A1 (en) 1987-04-29
IL80376A0 (en) 1987-01-30
ES2029785T3 (es) 1992-10-01
JPS62175192A (ja) 1987-07-31
CA1297814C (en) 1992-03-24
KR880001813A (ko) 1988-04-27
EP0219814B1 (en) 1991-09-11
JPH07114702B2 (ja) 1995-12-13

Similar Documents

Publication Publication Date Title
DK362686A (da) Alkalisk protease, fremgangsmaade til fremstilling af hybridvektorer og genetisk transformerede mikroorganismer
DK0670896T3 (da) Kloning og ekspression af biologisk aktivt alfa-galactosidase A
AU588793B2 (en) Method of expressing alpha-1-antitrypsin in bacteria
NO895028D0 (no) Ny chimerisk transformerende vekstfaktor-beta.
EP0196042A3 (en) Antibiotic prepared from lysobacter sp. sc 14,067
DK502786D0 (da) Fremgangsmaade til fremstilling af en vaekstfaktor
DE3071292D1 (en) Recombinant bacteriophage for heterologous cloning of bacillus microorganisms and method for its production
NO175318C (no) Hybridgen for veksthormonfrigjörende faktor, replikerbar mikrobiell ekspresjonsvektor inneholdende et slikt gen, samt mikroorganisme transformert med en slik vektor og hybridpolypeptid som inneholder en Trp-GRF
DE69023101D1 (de) Bakterielles Kollagenase-Gen.
AU604475B2 (en) The gal operon streptomyces
ES2071108T3 (es) Metodo eficiente para expresion identificable de genes no seleccionables.
GR3007491T3 (da)
AU4682685A (en) Recombinant saccharomyces
DK0504798T3 (da) Fremgangsmåde til fremstilling af glutarylacylase i store mængder
ATE78870T1 (de) Verfahren zur herstellung von neutraler protease.
EP0064681A3 (en) Novel recombinant dna
HU9203485D0 (en) Method for producing new plasmides
ATE52805T1 (de) Psm112-plasmidvektor zur expression in bacillus subtilis.
ES8607390A1 (es) Metodo de detectar acidos nucleicos.
ATE122097T1 (de) Expressionsvektor und verfahren zur regulierbaren herstellung von proteinen in eukaryonten.
AU2057688A (en) Alpha-amidating enzyme compositions and processes for their production and use